MMI-166, a selective matrix metalloproteinase inhibitor, promotes apoptosis in human pancreatic cancer. [electronic resource]
Producer: 20160209Description: 418 p. digitalISSN:- 1559-131X
- Animals
- Apoptosis -- drug effects
- Biomarkers, Tumor -- metabolism
- Down-Regulation
- Humans
- Male
- Matrix Metalloproteinase 2 -- metabolism
- Matrix Metalloproteinase 9 -- metabolism
- Matrix Metalloproteinase Inhibitors -- pharmacology
- Mice
- Mice, Inbred BALB C
- Mice, Nude
- Pancreatic Neoplasms -- metabolism
- Proto-Oncogene Proteins c-myc -- metabolism
- Sulfonamides -- pharmacology
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.